Despite the ongoing difficulties presented by the pandemic, 2021 witnessed a remarkable number of vital tumor conferences, spanning continents and focusing on breaking research, new treatment modalities, and improved patient experiences. From the American Society of Clinical Oncology (ASCO) Virtual Congress in April, which showcased groundbreaking